Profilo
Martin Schwarz is the founder of Synapticon GmbH, which he founded in 2010 and where he holds the title of Senior System Engineer.
He is currently working as a Director at Boehringer Ingelheim Corp.
Posizioni attive di Martin Schwarz
| Società | Posizione | Inizio |
|---|---|---|
Synapticon GmbH
 Synapticon GmbH Engineering & ConstructionIndustrial Services Synapticon GmbH components and engineering services. The firm’s solutions include target-optimized hardware designs and development of special applications. The company was founded by Andrija Feher, Martin Schwarz and Nikolai Ensslen in 2010 and is headquartered in Schonaich, Germany. | Fondatore | 01/01/2010 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Synapticon GmbH
Synapticon GmbH Engineering & ConstructionIndustrial Services Synapticon GmbH components and engineering services. The firm’s solutions include target-optimized hardware designs and development of special applications. The company was founded by Andrija Feher, Martin Schwarz and Nikolai Ensslen in 2010 and is headquartered in Schonaich, Germany. | Industrial Services |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
- Borsa valori
- Insiders
- Martin Schwarz
